ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 17 filers reported holding ARCA BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $35,000 | +12.9% | 93,258 | 0.0% | 0.02% | +6.7% |
| Q4 2018 | $31,000 | -46.6% | 93,258 | 0.0% | 0.02% | -42.3% |
| Q3 2018 | $58,000 | +11.5% | 93,258 | 0.0% | 0.03% | +13.0% |
| Q2 2018 | $52,000 | +10.6% | 93,258 | 0.0% | 0.02% | +15.0% |
| Q1 2018 | $47,000 | -62.7% | 93,258 | 0.0% | 0.02% | -52.4% |
| Q4 2017 | $126,000 | +17.8% | 93,258 | -0.0% | 0.04% | +13.5% |
| Q3 2017 | $107,000 | -52.4% | 93,268 | -0.4% | 0.04% | -53.2% |
| Q2 2017 | $225,000 | +82.9% | 93,667 | +93.7% | 0.08% | +75.6% |
| Q1 2017 | $123,000 | -81.4% | 48,345 | -79.1% | 0.04% | -76.1% |
| Q4 2016 | $661,000 | – | 231,775 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aveo Capital Partners, LLC | 93,258 | $35,000 | 0.02% |
| Tekla Capital Management LLC | 811,227 | $303,000 | 0.01% |
| BANK OF AMERICA CORP /DE/ | 576 | $0 | 0.00% |
| NORTHERN TRUST CORP | 13,986 | $5,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 48,679 | $18,000 | 0.00% |
| MORGAN STANLEY | 2,000 | $1,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 219,236 | $82,000 | 0.00% |
| BlackRock Inc. | 865 | $0 | 0.00% |
| Citadel Advisors | 81,938 | $31,000 | 0.00% |